Emmaus Life Sciences, Inc.（EMMA）· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。

FMP · EMMA · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income

Breakdown	2025-12	2024-12	2023-12	2022-12	2021-12
Revenue
Revenue	$12.45M	$16.65M	$29.60M	$18.39M	$20.61M
Cost of Revenue	$0.86M	$1.20M	$1.34M	$2.59M	$3.31M
Gross Profit	$11.60M	$15.45M	$28.25M	$15.80M	$17.30M
Gross Margin %(computed)	93.12%	92.79%	95.47%	85.93%	83.93%
Operating Expenses
R&D Expenses	$0.31M	$0.66M	$1.19M	$1.73M	$4.11M
G&A Expenses	$8.18M	$10.69M	$14.89M	$13.17M	$13.44M
Total Operating Expenses	$11.37M	$17.35M	$24.71M	$22.39M	$23.43M
Operating Income	$0.23M	($1.89M)	$3.54M	($6.59M)	($6.13M)
Operating Margin %(computed)	1.85%	-11.37%	11.96%	-35.81%	-29.73%
Interest Income	$0.27M	$0.27M	$0.68M	$0.68M	$0.76M
Interest Expense	$7.13M	$5.49M	$7.38M	$5.01M	$3.10M
Income Before Tax	($7.48M)	($6.42M)	($3.79M)	($10.56M)	($15.92M)
Income Tax Expense	$0.01M	$0.03M	($0.06M)	$0.06M	$0.03M
Net Income	($7.49M)	($6.45M)	($3.73M)	($10.63M)	($15.95M)
Net Margin %(computed)	-60.16%	-38.75%	-12.61%	-57.78%	-77.37%
Per Share & EBITDA
EPS (Basic)	$-0.12	$-0.10	$-0.07	$-0.21	$-0.32
Wtd Avg Shares	64.04M	63.23M	53.10M	49.44M	49.25M
EBITDA	($0.31M)	($0.91M)	$3.62M	($5.50M)	($12.76M)
EBITDA Margin %(computed)	-2.49%	-5.46%	12.24%	-29.90%	-61.92%